Geode Capital Management
IMGN

Geode Capital Management’s Immunogen Inc IMGN Stock Holding History

Geode Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,382,875
Closed -$160M – 4700
2023
Q4 		$160M Buy
5,382,875
+482,900
+10% +$9.62M 0.02% 630
2023
Q3 		$77.8M Buy
4,899,975
+147,425
+3% +$2.45M 0.01% 923
2023
Q2 		$89.7M Buy
4,752,550
+713,154
+18% +$8.42M 0.01% 856
2023
Q1 		$15.5M Buy
4,039,396
+200,306
+5% +$854K ﹤0.01% 1966
2022
Q4 		$19M Buy
3,839,090
+131,812
+4% +$715K ﹤0.01% 1801
2022
Q3 		$17.7M Buy
3,707,278
+21,497
+0.6% +$113K ﹤0.01% 1826
2022
Q2 		$16.6M Buy
3,685,781
+196,412
+6% +$853K ﹤0.01% 1885
2022
Q1 		$16.6M Sell
3,489,369
-57,398
-2% -$318K ﹤0.01% 2011
2021
Q4 		$26.3M Buy
3,546,767
+132,422
+4% +$823K ﹤0.01% 1771
2021
Q3 		$19.4M Sell
3,414,345
-218,231
-6% -$1.26M ﹤0.01% 1980
2021
Q2 		$23.9M Buy
3,632,576
+115,785
+3% +$808K ﹤0.01% 1847
2021
Q1 		$28.5M Buy
3,516,791
+470,188
+15% +$3.84M ﹤0.01% 1653
2020
Q4 		$19.6M Buy
3,046,603
+275,364
+10% +$1.61M ﹤0.01% 1732
2020
Q3 		$9.98M Sell
2,771,239
-23,950
-0.9% -$96.7K ﹤0.01% 1952
2020
Q2 		$12.9M Buy
2,795,189
+60,434
+2% +$257K ﹤0.01% 1783
2020
Q1 		$9.32M Buy
2,734,755
+314,740
+13% +$1.38M ﹤0.01% 1767
2019
Q4 		$12.4M Buy
2,420,015
+99,317
+4% +$337K ﹤0.01% 1865
2019
Q3 		$5.62M Buy
2,320,698
+149,857
+7% +$398K ﹤0.01% 2313
2019
Q2 		$4.71M Buy
2,170,841
+306,232
+16% +$724K ﹤0.01% 2435
2019
Q1 		$5.05M Buy
1,864,609
+146,839
+9% +$636K ﹤0.01% 2332
2018
Q4 		$8.24M Buy
1,717,770
+96,984
+6% +$588K ﹤0.01% 1906
2018
Q3 		$15.3M Buy
1,620,786
+102,624
+7% +$987K ﹤0.01% 1602
2018
Q2 		$14.8M Buy
1,518,162
+451,768
+42% +$4.76M ﹤0.01% 1580
2018
Q1 		$11.2M Buy
1,066,394
+111,201
+12% +$1.1M ﹤0.01% 1686
2017
Q4 		$6.12M Buy
955,193
+70,643
+8% +$436K ﹤0.01% 2096
2017
Q3 		$6.76M Buy
884,550
+171,360
+24% +$1.14M ﹤0.01% 2017
2017
Q2 		$5.07M Buy
713,190
+34,847
+5% +$159K ﹤0.01% 2137
2017
Q1 		$2.63M Buy
678,343
+22,991
+4% +$67.1K ﹤0.01% 2504
2016
Q4 		$1.34M Buy
655,352
+15,760
+2% +$31.6K ﹤0.01% 2851
2016
Q3 		$1.71M Buy
639,592
+18,448
+3% +$53.6K ﹤0.01% 2649
2016
Q2 		$1.91M Buy
621,144
+749
+0.1% +$4.7K ﹤0.01% 2514
2016
Q1 		$5.29K Buy
620,395
+31,625
+5% +$268K ﹤0.01% 1837
2015
Q4 		$7.99M Sell
588,770
-3,730
-0.6% -$45.9K ﹤0.01% 1533
2015
Q3 		$5.69M Buy
592,500
+21,032
+4% +$307K ﹤0.01% 1759
2015
Q2 		$8.22M Buy
571,468
+21,781
+4% +$239K ﹤0.01% 1554
2015
Q1 		$4.92M Buy
549,687
+16,035
+3% +$116K ﹤0.01% 1868
2014
Q4 		$3.25M Buy
533,652
+54,265
+11% +$496K ﹤0.01% 2098
2014
Q3 		$5.08M Sell
479,387
-2,684
-0.6% -$30.4K ﹤0.01% 1763
2014
Q2 		$5.71M Buy
482,071
+1,651
+0.3% +$20.7K ﹤0.01% 1710
2014
Q1 		$7.17M Buy
480,420
+57,322
+14% +$904K ﹤0.01% 1489
2013
Q4 		$6.21M Buy
423,098
+14,933
+4% +$229K ﹤0.01% 1534
2013
Q3 		$6.95M Buy
408,165
+39,578
+11% +$696K 0.01% 1327
2013
Q2 		$6.12M Buy
+368,587
New +$5.97M 0.01% 1267

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Geode Capital Management's IMGN Position: Q1 2024 in Review

Geode Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 5,382,875 shares — an estimated $160M sold.

Geode Capital Management first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $160M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Geode Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Geode Capital Management sold 5,382,875 Immunogen Inc shares in Q1 2024, an estimated $160M.
  • Geode Capital Management first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • Geode Capital Management's Immunogen Inc position peaked at $160M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.